Mary Tolan Overview

  • Investor Type
  • Angel

  • Investments
  • 3

  • Portfolio
  • 2

  • Exits
  • 1


Mary Tolan General Information


Ms. Mary Tolan is a Co-Founder and serves as Managing Partner at Chicago Pacific Founders. She serves as Board Member at Tredence. She serves as Board Member at Peel Therapeutics. She also serves as Advisor at She serves as Board Member at Atrio Health Plans. She serves as Board Member at Healthbox. She was also the founder of Accretive Health, a leading provider of comprehensive end-to-end healthcare revenue-cycle management services and population health management services infrastructure. Mary served as Accretive Health's Chief Executive Officer from November of 2003 to April of 2013 and served as Board Chair until November 2013. During that period Mary built Accretive Health from an idea into a billion dollar enterprise over a nine year period by building and leading a team of seasoned industry professionals focused on revolutionizing patient access and revenue-cycle processes for health- care providers. Mary led the IPO of Accretive Health in 2010 earning it a $1.2 billion market capitalization. Previously, Mary was a Group Chief Executive at Accenture, the $64 billion market cap global management consulting, technology services, and outsourcing company. At Accenture she was the Group Chief Executive of a $2.3 billion global operating group. Mary also played a leadership role in taking Accenture public in 2001, one of that year's largest offerings on the New York Stock Exchange. Mary's accomplishments as a business leader have earned her many recognitions and awards including being named the EY Entrepreneur Of The Year 2010 National Winner in the Services Category and leading Accretive Health to be named the Illinois Venture Capital Association's Company of the Year in 2011. Mary serves on the Boards of trustees for the University of Chicago and Loyola University. She received a Bachelor of Business Administration degree from Loyola University and an MBA from the University of Chicago.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 980 North Michigan Avenue
  • Suite 1998
  • Chicago, IL 60611
  • United States
+1 (312) 000-0000

Mary Tolan Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
BioIntellisense 28-Jul-2021 Early Stage VC 0000 Monitoring Equipment Generating Revenue 0000 00000
00000.0000 15-Jun-2020 00000 00000 00000 Business/Productivity Software Generating Revenue 0000 00000
0000000 000000 02-Apr-2015 00000 00000 000 Other Healthcare Technology Systems Generating Revenue 0000 00000

Mary Tolan Exits (1)

Company Name Exit Date Exit Type Exit Size
00000.0000 10-May-2022 000000000000000000

Mary Tolan Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Mary Tolan Team (1)

Name Title Deals Funds Boards Office
Mary Tolan Angel Investor 00 0 0 Chicago, IL

Mary Tolan Co-Investors (11)

Name With Exits Lead Partner Series Industry
Fresenius Medical Care 1 0 Series chart Industry bar
Pendrell 0 0 Series chart Industry bar
Philips Ventures 0 0 Series chart Industry bar
Royal Philips Electronics (Restoratives and Impression Portfolios) 0 0 Series chart Industry bar
TT Capital Partners 0 0 Series chart Industry bar